Factors Influencing Treatment Decisions among Breast Cancer Patients in the Philippine General Hospital Cancer Institute—Medical Oncology Outpatient Clinic

Abstract Introduction Breast cancer is a chronic disease and its treatment decisions exist over a relatively long time period. This study was done to identify factors influencing treatment decisions among breast cancer patients in the Philippine General Hospital Cancer Institute–Medical Oncology Outpatient Clinic. Materials and Methods This was a cross-sectional study that made use of a questionnaire and structured interview. Descriptive statistics were utilized in the analysis of the data. This allowed identification of patient demographics, economic profile, cancer profile, sources of financial or medical assistance, and summary of patient’s responses to identify the factors influencing treatment decisions among breast cancer patients. Results A total of 272 participants were included. This study identified the following factors as having influence on treatment decisions: high level of satisfaction to the consultation with their attending physician, caring and sincere communication about prognosis and likelihood of benefit from treatment, family as person of influence, the patient’s collaborative role in the decision making process, the desire of cure, and trust with their doctors. Conclusion Health practices and treatment decisions among Filipino breast cancer patients are widely affected by an interplay of the following factors: family, community, doctor’s recommendations, patient’s satisfaction and participation in the decision-making, health care access, and adverse treatments.

Download Full-text

Factors influencing treatment decisions among breast cancer patients in the Philippine general hospital cancer institute: Medical oncology outpatient clinic

Annals of Oncology ◽

10.1093/annonc/mdz430.009 ◽

2019 ◽

Vol 30 ◽

pp. ix120

Author(s):

B.G. De Guzman ◽

N.F. Cabaya ◽

F.I.L. Ting ◽

J.S. Tan

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

General Hospital ◽

Outpatient Clinic ◽

Medical Oncology ◽

Treatment Decisions ◽

Breast Cancer Patients ◽

Factors Influencing

Download Full-text

Young breast cancer patients' involvement in treatment decisions: the major role played by decision-making about surgery

Psycho-Oncology ◽

10.1002/pon.3316 ◽

2013 ◽

Vol 22 (11) ◽

pp. 2546-2556 ◽

Cited By ~ 13

Author(s):

Valérie Seror ◽

Sébastien Cortaredona ◽

Anne-Deborah Bouhnik ◽

Mégane Meresse ◽

Camille Cluze ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Cancer Patients ◽

Treatment Decisions ◽

Breast Cancer Patients ◽

Young Breast Cancer

Download Full-text

Decision-making from multidisciplinary team meetings to the bedside: Factors influencing the recruitment of breast cancer patients into clinical trials

The Breast ◽

10.1016/j.breast.2013.12.008 ◽

2014 ◽

Vol 23 (2) ◽

pp. 170-174 ◽

Cited By ~ 5

Author(s):

Chafika Mazouni ◽

Jacqueline Deneuve ◽

Monica Arnedos ◽

Fanny Prenois ◽

Mahasti Saghatchian ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Clinical Trials ◽

Cancer Patients ◽

Multidisciplinary Team ◽

Breast Cancer Patients ◽

Team Meetings ◽

Factors Influencing ◽

Multidisciplinary Team Meetings

Download Full-text

Discrepancies in three commercial prognostic breast cancer assays used in adjuvant chemotherapy decisions.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.26_suppl.84 ◽

2014 ◽

Vol 32 (26_suppl) ◽

pp. 84-84

Author(s):

Ashrei Y Bayewitz ◽

Jeffrey Gary Schneider ◽

Lorna Ogden ◽

George Turi

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Adjuvant Chemotherapy ◽

Decision Analysis ◽

Cancer Patients ◽

Recurrence Risk ◽

Treatment Decisions ◽

Risk Category ◽

Breast Cancer Patients ◽

Large Patient

84 Background: OT (Oncotype DX), MS (Mammostrat) and MP (Mammaprint) are three prognostic measures of breast cancer recurrence risk. All three were retrospectively validated in large patient cohorts and are now used when deciding on risk-reducing adjuvant chemotherapy. Our objective was to directly compare these three assays and their potential for differential effects on adjuvant chemotherapy decision making. Methods: We have previously reported that OT reduces adjuvant chemotherapy utilization, whereas MS did not exhibit this same net tendency in identical patients. In this study, we performed MP assays in 31 ER+ N0 breast cancer patients for which we already had OT and MS results. Decision analysis was applied to determine changes in management that would be most likely depending on which assay was used to guide decision making. Results: Our decision analysis demonstrated that in a substantial proportion of breast cancer patients, each of the three assays led to changes in adjuvant treatment decisions compared with what would have been chosen based upon conventional criteria alone. OT changed the decision in 55% of patients, and MS and MP would have changed those decisions in 45% and 65% of patients, respectively. In two-by-two paired analyses, treatment decisions would have differed in 61% of cases for OT versus MS; 29% for OT versus MP and 38% for MS versus MP. OT had the greatest tendency to eliminate adjuvant chemotherapy use (in 55% of patients versus MS and in 22% of patients versus MP), whereas MS had the greatest tendency to increase chemotherapy use (in 55% of patients versus OT and 35% versus MP). Conclusions: In this study of 31ER+ N0 breast cancer patients, three commercially available prognostic assays (OT, MS and MP) often yielded discordant risk category results. Our decision analysis suggests that these discordant results may frequently lead to different chemotherapy choices based upon which assay had been selected to guide decision making.

Download Full-text

Validation of the Malay, English, and Chinese Translations of the 9-Item Shared Decision Making Questionnaire (SDM-Q-9) in Breast Cancer Patients Making Treatment Decisions

Asia Pacific Journal of Public Health ◽

10.1177/10105395211036625 ◽

2021 ◽

pp. 101053952110366

Author(s):

Bairave Shunnmugam ◽

Chirk Jenn Ng ◽

Nur Aishah Mohd Taib ◽

Karuthan Chinna

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Cancer Patients ◽

Shared Decision Making ◽

Reliability And Validity ◽

Treatment Decisions ◽

Shared Decision ◽

Breast Cancer Patients ◽

Good Reliability ◽

Back Translation

This study aims to test the psychometric properties of the Malay, English, and Chinese 9-Item Shared Decision Making Questionnaire (SDM-Q-9) in breast cancer patients making treatment decisions. The original German SDM-Q-9 was translated to Malay using the back-translation method. A total of 222 newly diagnosed breast cancer patients making treatment decisions were sampled conveniently from three breast clinics between August 2015 and February 2016. A total of 66 patients answered the SDM-Q-9 in Malay, 87 in English, and 69 in Chinese. Data were analyzed using SPSS and AMOS software. SDM-Q-9 demonstrated good reliability in the three translations. All the items correlated well except for Item 1 in English. The factor loadings were within acceptable range except for Item 1 in Malay, Items 1 and 2 in English, and Items 7 and 9 in Chinese SDM-Q-9. However, no items were deleted in accordance with experts’ opinions and the previous SDM-Q-9 validation studies. The Malay, English, and Chinese SDM-Q-9 demonstrated good reliability and validity.

Download Full-text

The relationship of self-acceptance with decision making duration in cancer patient to perform mastectomy

Breast Disease ◽

10.3233/bd-219016 ◽

2021 ◽

pp. 1-5

Author(s):

Ayu Ratuati Setiawan ◽

Feny Tunjungsari ◽

Mochamad Aleq Sander

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Cross Sectional ◽

Abnormal Growth ◽

Self Acceptance ◽

Observation Method ◽

Relationship Of ◽

The Relationship

BACKGROUND: Cancer is a disease caused by abnormal growth of body cells that turn malignant and continue to grow uncontrollably. One of the treatments for breast cancer is mastectomy. The quickness of decision-making determines the survival rate of prognosis patients. OBJECTIVE: This study aimed to determine the relationship of self-acceptance with decision-making duration in cancer patients to perform a mastectomy. METHODS: An analytic observation method with cross-sectional design. The samples were taken by purposive sampling method with 50 samples of breast cancer patients. Data collected include age, last level of education, marital status, profession, stage of cancer during mastectomy, self-acceptance score, and decision-making duration to perform a mastectomy. RESULTS: The data analyzed with the Kruskal–Wallis test. The test showed the relationship of self-acceptance (p = 0.027) with decision-making duration in breast cancer patients to perform a mastectomy. CONCLUSION: In Conclusion, there is a relationship of self-acceptance with decision-making duration in breast cancer patients to perform a mastectomy.

Download Full-text